Hims & Hers Health (HIMS) Competitors $54.94 +1.69 (+3.18%) Closing price 09/25/2025 03:59 PM EasternExtended Trading$54.54 -0.41 (-0.74%) As of 09/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HIMS vs. NTRA, GH, RDNT, BTSG, OPCH, SHC, WGS, SGRY, PRVA, and VCYTShould you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Natera (NTRA), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Option Care Health (OPCH), Sotera Health (SHC), GeneDx (WGS), Surgery Partners (SGRY), Privia Health Group (PRVA), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. Hims & Hers Health vs. Its Competitors Natera Guardant Health RadNet BrightSpring Health Services Option Care Health Sotera Health GeneDx Surgery Partners Privia Health Group Veracyte Hims & Hers Health (NYSE:HIMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, dividends, risk, valuation, earnings and institutional ownership. Do analysts prefer HIMS or NTRA? Hims & Hers Health presently has a consensus target price of $38.92, suggesting a potential downside of 29.17%. Natera has a consensus target price of $192.88, suggesting a potential upside of 17.86%. Given Natera's stronger consensus rating and higher possible upside, analysts plainly believe Natera is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 3 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92Natera 0 Sell rating(s) 1 Hold rating(s) 17 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more risk and volatility, HIMS or NTRA? Hims & Hers Health has a beta of 2.14, indicating that its stock price is 114% more volatile than the S&P 500. Comparatively, Natera has a beta of 1.68, indicating that its stock price is 68% more volatile than the S&P 500. Is HIMS or NTRA more profitable? Hims & Hers Health has a net margin of 9.63% compared to Natera's net margin of -12.89%. Hims & Hers Health's return on equity of 26.26% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health9.63% 26.26% 13.06% Natera -12.89%-22.22%-15.03% Do insiders & institutionals hold more shares of HIMS or NTRA? 63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 13.7% of Hims & Hers Health shares are held by insiders. Comparatively, 5.6% of Natera shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media refer more to HIMS or NTRA? In the previous week, Hims & Hers Health had 15 more articles in the media than Natera. MarketBeat recorded 30 mentions for Hims & Hers Health and 15 mentions for Natera. Natera's average media sentiment score of 1.17 beat Hims & Hers Health's score of 0.61 indicating that Natera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 14 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Natera 7 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, HIMS or NTRA? Hims & Hers Health has higher earnings, but lower revenue than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$1.48B8.41$126.04M$0.8068.68Natera$1.70B13.24-$190.43M-$1.91-85.69 SummaryHims & Hers Health beats Natera on 9 of the 17 factors compared between the two stocks. Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIMS vs. The Competition Export to ExcelMetricHims & Hers HealthMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$12.04B$2.13B$5.74B$21.61BDividend YieldN/AN/A5.75%3.52%P/E Ratio68.6836.0275.7729.18Price / Sales8.4110.67544.5959.53Price / Cash151.2158.9837.5424.32Price / Book25.4410.8312.874.52Net Income$126.04M-$63.46M$3.29B$1.00B7 Day Performance-4.84%0.23%0.26%-0.84%1 Month Performance20.75%-0.96%2.85%1.80%1 Year Performance210.24%33.37%65.65%12.54% Hims & Hers Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HIMSHims & Hers Health2.3977 of 5 stars$54.94+3.2%$38.92-29.2%+218.4%$12.04B$1.48B68.681,637Insider TradeGap DownNTRANatera3.5722 of 5 stars$179.79-0.7%$192.88+7.3%+30.9%$24.68B$1.70B-94.134,434Positive NewsGHGuardant Health4.0057 of 5 stars$60.11+1.6%$59.00-1.8%+169.9%$7.49B$828.85M-17.922,021Trending NewsAnalyst ForecastGap UpRDNTRadNet3.0308 of 5 stars$75.48-1.3%$76.80+1.7%+6.0%$5.82B$1.83B-378.3011,021BTSGBrightSpring Health Services1.9396 of 5 stars$27.310.0%$27.10-0.8%+79.5%$4.85B$11.27B88.2435,000Positive NewsGap DownOPCHOption Care Health4.8583 of 5 stars$28.73+1.5%$35.75+24.4%-13.5%$4.66B$5.37B22.998,088Positive NewsAnalyst ForecastSHCSotera Health2.3881 of 5 stars$16.07+2.8%$16.00-0.4%-6.3%$4.56B$1.10B200.593,000Positive NewsWGSGeneDx2.1165 of 5 stars$129.43-0.1%$104.13-19.5%+206.6%$3.72B$305.45M2,588.501,200SGRYSurgery Partners2.9328 of 5 stars$21.85+1.1%$32.88+50.5%-33.1%$2.80B$3.11B-15.2715,000PRVAPrivia Health Group4.3206 of 5 stars$22.69+1.4%$28.58+26.0%+33.2%$2.78B$1.74B206.291,140Trending NewsAnalyst ForecastAnalyst RevisionVCYTVeracyte3.7022 of 5 stars$34.50+1.1%$40.90+18.6%-1.6%$2.71B$479.13M104.45790Gap Down Related Companies and Tools Related Companies NTRA Competitors GH Competitors RDNT Competitors BTSG Competitors OPCH Competitors SHC Competitors WGS Competitors SGRY Competitors PRVA Competitors VCYT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HIMS) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
